The documents in this background package include:

 

Cover Memorandum  [WORD] [PDF] [HTML]

 

TAB 1       General background document for Aredia and Zometa  [WORD] [PDF] [HTML]

 

FDA/CDER Office of Drug Safety (ODS) Postmarketing Memorandum/Review

TAB 2       November 21, 2003 Memorandum [PDF]

 

TAB 3       August 25, 2004 Review   [PDF]

 

Other References

Bibliography  [WORD] [PDF] [HTML]